MANHASSET, N.Y. Bioident, a subsidiary of Nanoident Technologies AG, has opened a new headquarters in Menlo Park, Calif.
Bioident, which specializes in organic semiconductor-based photonics, also said it has appointed two executives with expertise in nanotechnology, printed organic semiconductors and biophotonics.
"By forming a dedicated subsidiary in the U.S., we further the proliferation of Nanoident technology globally with the specific resources and
expertise required for life sciences," Nanoident CEO Klaus Schroeter said in a statement. Nanoident (Linz, Austria) develops organic semiconductors.
"Bioident technology represents the ideal marriage of printed organic optoelectronic components and microfluidics," added new Bioident CEO Wasiq Bokhari. Bokhari is a co-founder of Quantum Insight, which works with startups on life sciences, energy and semiconductor applications.
New CTO Max Sonnleitner will continue overseeing development of core technologies in support of emerging applications.
Bioident's lab-on-a-chip targets applications like mobile water and food analysis, chemical and biological agent detection and in-vitro diagnostics. Combined, the applications represent an estimated $7.5 billion market.
Bioident also unveiled a platform called PhotonicLab, which is designed as a platform for future lab-on-a-chip systems. It integrates on-chip photonic readout capabilities, the company said.